Chemistry and structural biology of androgen receptor
W Gao, CE Bohl, JT Dalton - Chemical reviews, 2005 - ACS Publications
Androgen receptor (AR) is a member of the steroid and nuclear receptor superfamily, 1
which is composed of over 100 members and continues to grow. Among this large family of …
which is composed of over 100 members and continues to grow. Among this large family of …
[HTML][HTML] The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
RE Vickman, OE Franco, DC Moline… - Asian journal of …, 2020 - Elsevier
Benign prostatic hyperplasia (BPH) is a benign enlargement of the prostate in which
incidence increases linearly with age, beginning at about 50 years old. BPH is a significant …
incidence increases linearly with age, beginning at about 50 years old. BPH is a significant …
[HTML][HTML] Gene ontology analysis for RNA-seq: accounting for selection bias
We present GOseq, an application for performing Gene Ontology (GO) analysis on RNA-seq
data. GO analysis is widely used to reduce complexity and highlight biological processes in …
data. GO analysis is widely used to reduce complexity and highlight biological processes in …
Molecular determinants of resistance to antiandrogen therapy
CD Chen, DS Welsbie, C Tran, SH Baek, R Chen… - Nature medicine, 2004 - nature.com
Using microarray-based profiling of isogenic prostate cancer xenograft models, we found
that a modest increase in androgen receptor mRNA was the only change consistently …
that a modest increase in androgen receptor mRNA was the only change consistently …
[HTML][HTML] Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra… - Cancer cell, 2005 - cell.com
Molecular profiling of cancer at the transcript level has become routine. Large-scale analysis
of proteomic alterations during cancer progression has been a more daunting task. Here, we …
of proteomic alterations during cancer progression has been a more daunting task. Here, we …
[HTML][HTML] Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
The histone methyltransferase DOT1L methylates lysine 79 (K79) on histone H3 and is
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein, P Lal, E LaTulippe, A Smith… - The American journal of …, 2004 - Elsevier
The androgen-signaling pathway is critical to the development and progression of prostate
cancer and androgen ablation is a mainstay of therapy for this disease. We performed a …
cancer and androgen ablation is a mainstay of therapy for this disease. We performed a …
Long-range gene regulation in hormone-dependent cancer
The human genome is organized into multiple structural layers, ranging from chromosome
territories to progressively smaller substructures, such as topologically associating domains …
territories to progressively smaller substructures, such as topologically associating domains …
Molecular regulation of androgen action in prostate cancer
SM Dehm, DJ Tindall - Journal of cellular biochemistry, 2006 - Wiley Online Library
Androgens are critical regulators of prostate differentiation and function, as well as prostate
cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment …
cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment …
Cell-and gene-specific regulation of primary target genes by the androgen receptor
EC Bolton, AY So, C Chaivorapol… - Genes & …, 2007 - genesdev.cshlp.org
The androgen receptor (AR) mediates the physiologic and pathophysiologic effects of
androgens including sexual differentiation, prostate development, and cancer progression …
androgens including sexual differentiation, prostate development, and cancer progression …